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Background: We have shown that selective intracoronary nitroprusside administration prior to percutaneous coronary intervention (PCI) prevents 
no- or slow-reflows, and improves reperfusion of the infarcted myocardium for acute myocardial infarction (AMI) in acute phase. We evaluated the 
effect of this therapy on left ventricular remodeling in chronic phase. 
Methods: We randomly assigned 122 consecutive patients with AMI to perform PCI with (nitroprusside group; 60 patients) or without this therapy 
(control group; 62 patients).In nitroprusside group, nitroprusside (120 μg) was selectively administered through the drug delivery catheter into the 
distal coronary artery to reach the target lesion before balloon dilatation. Angiographic data in the acute stage, clinical and echocardiograph data 
both at base line and 6-month after procedure of the nitroprusside group were compared with control group. 
Results: Nitroprusside group had less slow-reflow, a better blush grade, and a better corrected TIMI coronary flame count than control group as 
we have reported. Compared to control group, nitroprusside group had significantly: smaller percent changes of left ventricular end-diastolic volume 
(-8.4±12.4% vs. 11.5±20.7%, p<0.01); greater percent changes of left ventricular ejection fraction (7.7±8.1% vs. 1.1±10.3%, p<0.05); greater 
percent changes of left ventricular stroke volume (12.0±22.2% vs.-1.8±19.2%, p<0.05). 
Conclusions: The selective intracoronary nitroprusside administration prior to PCI prevents slow reflows, suppresses left ventricular remodeling, 
and improves left ventricular functional recovery at 6 months.
